Tuesday, August 11, 2026

UNESCO Delays Heritage Status for Japan’s Sado Mine Citing Forced Korean Labor

Media reports indicated a sense of disappointment in Niigata, Japan, where the Sado Mines, a site of forced labor during the ...

Pete Crow-Armstrong’s Dramatic Walk-Off: How Speed Secured the Cubs’ 3-2 Victory Over Blue Jays

Pete Crow-Armstrong led the Chicago Cubs to victory with speed, competing for MVP against Shohei Ohtani in MLB.

Meta and Google Found Guilty: 6.3 Million USD Verdict for Social Media Addiction Impact on Youth

Meta and Google were found guilty of designing harmful social media for youth, ordered to pay damages, and face more lawsuits ahead.

Tag: injection

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Alteogen Signs $365 Million License Deal With Global Pharma Company for SC Platform Technology

Alteogen has signed an exclusive licensing agreement with a global pharmaceutical company for the development of subcutaneous biopharmaceuticals.

Novo Nordisk’s Weekly Growth Hormone Sogroya Gains Reimbursement in Korea

Novo Nordisk's Sogroya gains insurance coverage, but market changes may be limited due to strong competitors and safety concerns.

Prompt Injection Attacks Are Targeting Corporate AI Agents as AI Security Threats Increase

AI agents are increasingly targeted by cyberattacks, necessitating enhanced security measures and a shift towards AI-driven cybersecurity.

2026’s Game-Changer: Canine Influenza Vaccine “CaniFlu-max” Now Approved for Subcutaneous Injection

A new subcutaneous influenza vaccine for dogs, CaniFlu-max, enhances treatment flexibility and has a strong safety profile.

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Worried About Your Child’s Height? What Growth Hormone Deficiency Could Mean

A father discovers his child’s height difference is due to growth hormone deficiency, considering treatment options and adherence challenges.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.